396074-99-0 Usage
Uses
Used in Organic Synthesis:
(5-CHLORO-2-FLUOROPHENYL)HYDRAZINE is used as a building block for the synthesis of various organic compounds, leveraging its reactivity and unique structural features to create a wide array of chemical products.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, (5-CHLORO-2-FLUOROPHENYL)HYDRAZINE is utilized as a reagent in chemical reactions, contributing to the development of new drugs and medicinal compounds. Its specific properties allow it to be integrated into the synthesis processes of pharmaceuticals, potentially leading to innovative treatments and therapies.
Used in Agrochemicals:
(5-CHLORO-2-FLUOROPHENYL)HYDRAZINE also finds application in the agrochemical industry, where it is employed in the synthesis of various agrochemical products. Its role in this field is crucial for the development of new pesticides, herbicides, and other agricultural chemicals that can improve crop yields and protect against pests.
Check Digit Verification of cas no
The CAS Registry Mumber 396074-99-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,6,0,7 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 396074-99:
(8*3)+(7*9)+(6*6)+(5*0)+(4*7)+(3*4)+(2*9)+(1*9)=190
190 % 10 = 0
So 396074-99-0 is a valid CAS Registry Number.
396074-99-0Relevant academic research and scientific papers
Anti-obesity 1,2,3,4,10,10-a-hexahydropy razino [1,2-a] indoles
-
, (2008/06/13)
The present invention is directed to 1,2,3,4,10,10a,-hexahydropyrazino[1,2-a] indole derivatives as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R8 have the significance given in claim 1 be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea.
